Methylnaltrexone Pharmacokinetics in Neurointensive Care Patients

NCT01889290 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Opioid Use, Unspecified With Other Opioid-induced Disorder

Interventions

DRUG: Methylnaltrexone

Sponsor

University of Zurich